Your browser doesn't support javascript.
loading
The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.
Feng, Q; Wei, W Q; Chung, C P; Levinson, R T; Bastarache, L; Denny, J C; Stein, C M.
Afiliação
  • Feng Q; Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Wei WQ; Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA.
  • Chung CP; Division of Rheumatology, Department of Medicine, Vanderbilt University, Nashville, TN, USA.
  • Levinson RT; Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USA.
  • Bastarache L; Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA.
  • Denny JC; Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA.
  • Stein CM; Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Pharmacogenomics J ; 17(2): 204-208, 2017 03.
Article em En | MEDLINE | ID: mdl-26902539
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Polimorfismo de Nucleotídeo Único / Dislipidemias / Pró-Proteína Convertase 9 / Variantes Farmacogenômicos / LDL-Colesterol Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Polimorfismo de Nucleotídeo Único / Dislipidemias / Pró-Proteína Convertase 9 / Variantes Farmacogenômicos / LDL-Colesterol Idioma: En Ano de publicação: 2017 Tipo de documento: Article